Insights Into Rhythm Pharmaceuticals Inc. (RYTM) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

Rhythm Pharmaceuticals Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $43.88 and fluctuated between $42.01 as its day high and $39.81 as its day low. The current market capitalization of Rhythm Pharmaceuticals Inc. is $2.64B. A total of 0.98 million shares were traded on the day, compared to an average of 581.11K shares.

In the most recent transaction, German Christopher Paul sold 368 shares of RYTM for 41.76 per share on Apr 02 ’24. After the transaction, the Corporate Controller & CAO now owns 795 company shares. In a previous transaction on Mar 21 ’24, Shulman Joseph sold 18,235 shares at 40.34 per share. RYTM shares that Chief Technical Officer owns now total 30.

Among the insiders who sold shares, Lee Jennifer Kayden disposed of 18,235 shares on Mar 20 ’24 at a per-share price of $38.77. This resulted in the EVP, Head of North America holding 6,852 shares of RYTM after the transaction. In another insider transaction, Meeker David P sold 45,494 shares at $39.22 per share on Mar 19 ’24. Company shares held by the President and CEO now total 174,605.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RYTM has a high of $52.57 and a low of $15.50.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RYTM’s latest balance sheet shows that the firm has $294.86M in Cash & Short Term Investments as of fiscal 2021. There were $2.55M in debt and $43.43M in liabilities at the time. Its Book Value Per Share was $2.86, while its Total Shareholder’s Equity was $284.15M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RYTM is Buy with a score of 4.89.

Most Popular

Related Posts